David Rawlings

Person

Santa Monica, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Homology directed repair compositions for the treatment of hemoglob...
- Patent number 12,110,499
- Issue date Oct 8, 2024
- Seattle Children's Hospital
- Andrew Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Rapamycin resistant cells
- Patent number 11,987,804
- Issue date May 21, 2024
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Engraftable cell-based immunotherapy for long-term delivery of ther...
- Patent number 11,939,594
- Issue date Mar 26, 2024
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for treating autoimmune disease using CD4 T-cells with engin...
- Patent number 11,712,454
- Issue date Aug 1, 2023
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expression of FOXP3 in edited CD34+ cells
- Patent number 11,713,459
- Issue date Aug 1, 2023
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked...
- Patent number 11,643,671
- Issue date May 9, 2023
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 10,745,690
- Issue date Aug 18, 2020
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enhancing endonuclease based gene editing in primary cells
- Patent number 10,563,226
- Issue date Feb 18, 2020
- Seattle Children's Hospital
- Andrew Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CCR5 disruption of cells expressing anti-HIV chimeric antigen recep...
- Patent number 10,494,422
- Issue date Dec 3, 2019
- Seattle Children's Hospital
- Thor Wagner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expression and purification of ATM protein using vaccinia virus
- Patent number 6,994,975
- Issue date Feb 7, 2006
- The Regents of the University of California
- Richard A. Gatti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hematopoietic restricted tyrosine kinase (BPK)
- Patent number 5,550,054
- Issue date Aug 27, 1996
- The Regents of the University of California
- Owen Witte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
VIVO GENE THERAPY USING INTRAOSSEOUS DELIVERY OF A LENTIVIRALGENE C...
- Publication number 20240366797
- Publication date Nov 7, 2024
- SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
- Carol Hsing MIAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAPAMYCIN RESISTANT CELLS
- Publication number 20240294946
- Publication date Sep 5, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...
- Publication number 20240287452
- Publication date Aug 29, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...
- Publication number 20240141389
- Publication date May 2, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...
- Publication number 20240124896
- Publication date Apr 18, 2024
- Seattle Children's Hospital (d/b/a Seattle Children's Research Institute)
- Andrew Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
- Publication number 20240117352
- Publication date Apr 11, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGIN...
- Publication number 20240033300
- Publication date Feb 1, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ARTIFICIAL ANTIGEN-SPECIFIC IMMUNOREGULATORY T (AIRT) CELLS
- Publication number 20230279351
- Publication date Sep 7, 2023
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Jane Buckner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR EDITING THE B2M LOCUS IN B CELLS
- Publication number 20230272431
- Publication date Aug 31, 2023
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
WISKOTT-ALDRICH SYNDROME GENE HOMING ENDONUCLEASE VARIANTS, COMPOSI...
- Publication number 20220364123
- Publication date Nov 17, 2022
- SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
- Joel GAY
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TALEN-BASED AND CRISPR/CAS-BASED GENE EDITING FOR BRUTON'S TYROSINE...
- Publication number 20220064651
- Publication date Mar 3, 2022
- Seattie Children's Hospital d/b/a Seattle Children's Research Institute
- David J. RAWLINGS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RAPAMYCIN RESISTANT CELLS
- Publication number 20210340573
- Publication date Nov 4, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC GENOME EDITING IN X-LINKED HYPER IGM SYNDROME
- Publication number 20210324381
- Publication date Oct 21, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HOMOLOGY-DIRECTED REPAIR TEMPLATE DESIGN AND DELIVERY TO EDIT HEMOG...
- Publication number 20210309995
- Publication date Oct 7, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION OF HUMAN FOXP3 IN GENE EDITED T CELLS
- Publication number 20210253652
- Publication date Aug 19, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IN VIVO GENE THERAPY USING INTRAOSSEOUS DELIVERY OF A LENTIVIRALGEN...
- Publication number 20210228742
- Publication date Jul 29, 2021
- SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
- Carol Hsing MIAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRUTON'S TYROSINE KINASE HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS...
- Publication number 20210230565
- Publication date Jul 29, 2021
- SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE
- David J. RAWLINGS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...
- Publication number 20210222201
- Publication date Jul 22, 2021
- Seattie Children's Hospital (dba Seattle Children's Research Institute)
- Andrew Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
- Publication number 20210054376
- Publication date Feb 25, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENHANCING ENDONUCLEASE BASED GENE EDITING IN PRIMARY CELLS
- Publication number 20200377911
- Publication date Dec 3, 2020
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...
- Publication number 20200325494
- Publication date Oct 15, 2020
- Seattle Children's Hospital dba ( Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTIMIZED LENTIVIRAL VECTOR FOR XLA GENE THERAPY
- Publication number 20200325458
- Publication date Oct 15, 2020
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IN VIVO GENE THERAPY FOR IMMUNE DEFICIENCIES
- Publication number 20200009266
- Publication date Jan 9, 2020
- Fred Hutchinson Cancer Research Center
- Frieda Chan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGIN...
- Publication number 20190247443
- Publication date Aug 15, 2019
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IDENTIFICATION AND PRODUCTION OF HIGH AFFINITY IGM ANTIBODIES AND D...
- Publication number 20190183997
- Publication date Jun 20, 2019
- University of Washington
- Marion PEPPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...
- Publication number 20180320165
- Publication date Nov 8, 2018
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...
- Publication number 20180282692
- Publication date Oct 4, 2018
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCING ENDONUCLEASE BASED GENE EDITING IN PRIMARY CELLS
- Publication number 20180119174
- Publication date May 3, 2018
- Seattle Children's Hospita (dba Seattle Children's Research Institute
- Andrew Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CCR5 DISRUPTION OF CELLS EXPRESSING ANTI-HIV CHIMERIC ANTIGEN RECEP...
- Publication number 20170044240
- Publication date Feb 16, 2017
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Thor WAGNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENHANCING ENDONUCLEASE BASED GENE EDITING IN PRIMARY CELLS
- Publication number 20160333377
- Publication date Nov 17, 2016
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

David Rawlings

Person

Patents Grantslast 30 patents

Homology directed repair compositions for the treatment of hemoglob...

Rapamycin resistant cells

Engraftable cell-based immunotherapy for long-term delivery of ther...

Method for treating autoimmune disease using CD4 T-cells with engin...

Expression of FOXP3 in edited CD34+ cells

Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked...

Coupling endonucleases with end-processing enzymes drives high effi...

Enhancing endonuclease based gene editing in primary cells

CCR5 disruption of cells expressing anti-HIV chimeric antigen recep...

Expression and purification of ATM protein using vaccinia virus

Hematopoietic restricted tyrosine kinase (BPK)

Patents Applicationslast 30 patents

VIVO GENE THERAPY USING INTRAOSSEOUS DELIVERY OF A LENTIVIRALGENE C...

RAPAMYCIN RESISTANT CELLS

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...

THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...

HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...

EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS

METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGIN...

ARTIFICIAL ANTIGEN-SPECIFIC IMMUNOREGULATORY T (AIRT) CELLS

METHODS AND COMPOSITIONS FOR EDITING THE B2M LOCUS IN B CELLS

WISKOTT-ALDRICH SYNDROME GENE HOMING ENDONUCLEASE VARIANTS, COMPOSI...

TALEN-BASED AND CRISPR/CAS-BASED GENE EDITING FOR BRUTON'S TYROSINE...

RAPAMYCIN RESISTANT CELLS

THERAPEUTIC GENOME EDITING IN X-LINKED HYPER IGM SYNDROME

HOMOLOGY-DIRECTED REPAIR TEMPLATE DESIGN AND DELIVERY TO EDIT HEMOG...

EXPRESSION OF HUMAN FOXP3 IN GENE EDITED T CELLS

IN VIVO GENE THERAPY USING INTRAOSSEOUS DELIVERY OF A LENTIVIRALGEN...

BRUTON'S TYROSINE KINASE HOMING ENDONUCLEASE VARIANTS, COMPOSITIONS...

HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...

EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS

ENHANCING ENDONUCLEASE BASED GENE EDITING IN PRIMARY CELLS

THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED...

OPTIMIZED LENTIVIRAL VECTOR FOR XLA GENE THERAPY

IN VIVO GENE THERAPY FOR IMMUNE DEFICIENCIES

METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGIN...

IDENTIFICATION AND PRODUCTION OF HIGH AFFINITY IGM ANTIBODIES AND D...

COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...

ENHANCING ENDONUCLEASE BASED GENE EDITING IN PRIMARY CELLS

CCR5 DISRUPTION OF CELLS EXPRESSING ANTI-HIV CHIMERIC ANTIGEN RECEP...

ENHANCING ENDONUCLEASE BASED GENE EDITING IN PRIMARY CELLS